Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (21-30 of 351) with videos related to

Pageof 36
Sort By:
Journal of Translational Medicine|July 26, 2014
Routing cancer immunology and immunotherapy from the lab to the clinic 4-5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, SpainM Ángela Aznar, Ignacio Melero, José I Quetglas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2019
Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to CrackDiego Salas-Benito, Ignacio Melero, Mariano Ponz-Sarvise
Cancer Discovery|October 2, 2021
Firefighters for the Wrong Type of Inflammation in TumorsIgnacio Melero, Alvaro Teijeira, Fernando Aranda, et al.
Oncoimmunology|December 21, 2023
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosisÁngela Bella, Ignacio Melero, Pedro Berraondo, et al.
Trends in Cancer|February 27, 2020
Premortem Tumor Stress in RadioimmunotherapyIgnacio Melero, Maite Alvarez, Luna Minute, et al.
Frontiers in Oncology|July 29, 2015
Melanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyMaria Libera Ascierto, Ignacio Melero, Paolo Antonio Ascierto
Science Translational Medicine|June 14, 2019
Twists and turns to translating 4-1BB cancer immunotherapyMiguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, et al.
Translational Lung Cancer Research|February 2, 2019
Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better?Jose Luis Perez-Gracia, Miguel F Sanmamed, Ignacio Melero
Drug Safety|January 17, 2019
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in CancerIosune Baraibar, Ignacio Melero, Mariano Ponz-Sarvise, et al.
Blood|November 10, 2017
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategiesCariad Chester, Miguel F Sanmamed, Jun Wang, et al.
Pageof 36

Showing results (21-30 of 351) with videos related to

Sort By:
Pageof 36
Journal of Translational Medicine|July 26, 2014
Routing cancer immunology and immunotherapy from the lab to the clinic 4-5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, SpainM Ángela Aznar, Ignacio Melero, José I Quetglas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2019
Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to CrackDiego Salas-Benito, Ignacio Melero, Mariano Ponz-Sarvise
Cancer Discovery|October 2, 2021
Firefighters for the Wrong Type of Inflammation in TumorsIgnacio Melero, Alvaro Teijeira, Fernando Aranda, et al.
Oncoimmunology|December 21, 2023
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosisÁngela Bella, Ignacio Melero, Pedro Berraondo, et al.
Trends in Cancer|February 27, 2020
Premortem Tumor Stress in RadioimmunotherapyIgnacio Melero, Maite Alvarez, Luna Minute, et al.
Frontiers in Oncology|July 29, 2015
Melanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyMaria Libera Ascierto, Ignacio Melero, Paolo Antonio Ascierto
Science Translational Medicine|June 14, 2019
Twists and turns to translating 4-1BB cancer immunotherapyMiguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, et al.
Translational Lung Cancer Research|February 2, 2019
Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better?Jose Luis Perez-Gracia, Miguel F Sanmamed, Ignacio Melero
Drug Safety|January 17, 2019
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in CancerIosune Baraibar, Ignacio Melero, Mariano Ponz-Sarvise, et al.
Blood|November 10, 2017
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategiesCariad Chester, Miguel F Sanmamed, Jun Wang, et al.
Pageof 36